Adobe | ADBE
AI is impacting software companies, and there is a view that it will inflict greater damage on software than on most other industries. This phenomenon is creating a new class…
AI is impacting software companies, and there is a view that it will inflict greater damage on software than on most other industries. This phenomenon is creating a new class…
On November 20, 2025, we argued that the Mag 7 stocks had reached a plateau and were likely to trade sideways for a while. To capitalize on this thesis, we…
The price of oil has been moving up over the last few days, and the financial media is getting more excited than a dog with two tails. This article is…
It's that time of the month again. Standard monthly options will expire at the end of the week. 13 trades will expire. 11 are in the black, and 2 are…
Bitcoin has been frustrating the bulls for at least a year. One should not be surprised, as the bullishness was off the charts. Name-brand players like Plan B and Thomas…
Vistra Corp agreed to pay $4 billion for 10 natural gas-fired power plants in the US Northeast and Texas to expand the electricity supplier’s generation capacity in fast-growing energy markets.…
I friend of mine who is an RIA asked me if I thought there was still time to get in on the memory chip mania. This article is for paid…
We have been fans of emerging markets for some time, as these stocks have performed well since the global financial crisis. Asia was weak, Latin America was weak, and so…
The Fed has cut short-term interest rates, and most people believe that this is good for interest rates. But what if it is not? This article is for paid members…
United Parcel Service (UPS) is an American multinational package delivery and supply chain management company, widely recognized as one of the world's largest logistics providers. This article is for paid…
The rally in precious metals prices has caught traditional stock investors by surprise. This phenomenon should not come as a big surprise to the gold and silver enthusiasts who have…
On December 22, 2025, the FDA approved Novo Nordisk's once-daily oral semaglutide (branded as the Wegovy pill), marking the first oral GLP-1 receptor agonist specifically for chronic weight management in…